ARVIDAL
DEAD

Serial Number

79307220

Owner

PVP LABS PTE. LTD.

Attorney

Matthew A. Homyk

Filing Date

Dec 11, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ARVIDAL Trademark

Serial Number: 79307220

ARVIDAL is a trademark filed by PVP LABS PTE. LTD. on December 11, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PVP LABS PTE. LTD. (2 trademarks)

1 COLEMAN STREET,

Entity Type: 99

Trademark Details

Filing Date

December 11, 2020

Registration Date

Not Registered

Published for Opposition

November 2, 2021

Goods & Services

pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely, by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses being Alpha-, Beta-, Gamma- and Deltacoronaviruses, severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology being multiple viral infections; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 5, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 14, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 14, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 31, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 12, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 12, 2022 OPNR
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 15, 2022 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Mar 14, 2022 ABN4
OPPOSITION TERMINATED NO. 999999
Mar 14, 2022 OP.T
OPPOSITION SUSTAINED NO. 999999
Mar 14, 2022 OP.S
REFUSAL PROCESSED BY IB
Dec 13, 2021 RFNT
OPPOSITION INSTITUTED NO. 999999
Nov 22, 2021 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 16, 2021 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 16, 2021 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Nov 15, 2021 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 28, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 24, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 2, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 2, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 2, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jul 1, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2021 DOCK
ASSIGNED TO EXAMINER
Jun 4, 2021 DOCK
ASSIGNED TO EXAMINER
Jun 3, 2021 DOCK
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 13, 2021 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
May 10, 2021 CRCV
APPLICATION FILING RECEIPT MAILED
Apr 2, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 29, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 25, 2021 REPR